Purchase Order 75F40118P10141
Award Date 5/29/18
Potential Completion Date 5/28/20
Potential Value $84K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Great Britain, United Kingdom
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Food and Drug Administration (FDA) awarded a $105,468.00 firm fixed price purchase order contract to Lhasa LIMITED, a non-profit organization based in the United Kingdom. The contract is for the LHASA KNOWLEDGE SUITE NEXUS, which includes the Derek, Meteor, Vitic, Sarah, and Zeneth software platforms. These advanced tools support chemical safety research, risk assessment, and environmental impact analysis for the FDA and other federal agencies. The contract has an ultimate completion...
- The U.S. Environmental Protection Agency's Office of Research and Development awarded a Purchase Order contract to Lhasa LIMITED for an annual software license renewal covering Derek Nexus and Meteor Nexus products. The contract, valued at $13,896, was awarded on March 19, 2024, with a completion date of April 12, 2025. This sole source award was made without a set-aside designation and represents a firm fixed price procurement for specialized software tools used in chemical safety assessment...
- This federal contract award is for a subscription to software products from Lhasa LIMITED, a non-profit organization based in the United Kingdom. The contract, valued at $13,952.00, is a Firm Fixed Price Purchase Order awarded by the Office of Chemical Safety and Pollution Prevention, a division of the U.S. Environmental Protection Agency (EPA). The software being provided includes the Derek Nexus, Meteor Nexus, and Sarah Nexus tools, which support the EPA's research and regulatory activities...
- The U.S. Food and Drug Administration (FDA) awarded a firm fixed price purchase order to Certara UK Limited, doing business as Certara, a for-profit limited liability company, for SIMCYP software licenses and maintenance support. The $114,316.00 contract will allow the FDA's Office of Clinical Pharmacology Drug Reviewers to complete their review of investigational new drugs. Certara has previously provided this physiologically-based pharmacokinetic modeling software to the FDA and...
- The Food and Drug Administration awarded a firm fixed-price purchase order to Certara UK LIMITED (doing business as Certara) on September 6, 2023, for SIMCYP software licenses with a ceiling value of $815,948. The contract will be performed in Great Britain, United Kingdom, and is scheduled for ultimate completion by September 20, 2028. No set-aside designation was applied to this award. Certara provides physiologically-based pharmacokinetic (PBPK) modeling software that simulates drug...
- This firm-fixed price purchase order contract was awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Certara UK LIMITED, doing business as Certara, a for-profit limited liability company. The $164,400 contract provides annual licenses and maintenance support for Certara's SIMCYP physiologically-based pharmacokinetic modeling software. The software is used by the FDA's Office of Clinical Pharmacology to review submissions from pharmaceutical sponsors,...
- The Department of Health and Human Services' Food and Drug Administration awarded a $43,243.20 firm fixed price purchase order to Certara USA Inc. for SEND EXPLORER licenses. The place of performance is Silver Spring, Maryland. The one-year contract runs from September 12, 2023 through September 14, 2024. Certara USA Inc. will provide the FDA with software licenses to support the agency's regulatory science and public health protection missions. No subcontractors or set asides were identified....
- The Department of Health and Human Services Food and Drug Administration awarded a $65,292 delivery order to Lyme Computer Systems, Inc. for the renewal of MATLAB software licenses. The prime contractor, Lyme Technology Solutions, will deliver the requested products under Solutions for Enterprise Wide Procurement V, a governmentwide acquisition contract vehicle. Performance will take place in Silver Spring, Maryland over one year beginning June 30, 2023. As the regulatory agency responsible...
- The Department of Health and Human Services, Food and Drug Administration awarded a fixed-price purchase order contract to Certara USA Inc., doing business as Tripos (De), for an annual Phoenix Quantum software subscription. The contract, with a potential value of $216,547.78, provides the FDA's Office of Clinical Pharmacology with the necessary modeling and simulation tools to analyze and verify sponsor submissions, including Investigational New Drug, New Drug, Biologics Licensing, and...
- The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a delivery order contract to Core Informatics, LLC, a subsidiary of Thermo Fisher Scientific, for a Platform for Science subscription licenses. The $316,257.50 firm fixed price contract will provide the FDA with access to Core Informatics' electronic laboratory notebook (ELN) and laboratory information management system (LIMS) software, as well as engineering support services, from May 2024 through May...
The U.S. Food and Drug Administration (FDA) awarded a $83,981 firm-fixed-price purchase order contract to Lhasa LIMITED, a non-profit organization based in the United Kingdom. The contract is for the provision of Lhasa's suite of software tools, including Derek Nexus, Meteor Nexus, VITIC Nexus, Sarah Nexus, and Zeneth. These predictive toxicology and metabolism software products support the FDA's research and regulatory activities related to chemical safety and environmental protection. The contract has a performance period ending on May 28, 2020. No set-aside designation was used for this award, indicating that Lhasa LIMITED competed for the opportunity in the open market.
Generated 4/2/25, 6:59 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Exercise an Option | $24.9k | 4/17/19 | |
| Not listed | Not listed | $59.0k | 5/29/18 |